# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Know Labs (AMEX:KNW) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 16....
Each unit consisting of one share of its common stock and one warrant to purchase one share of its common stock at an initial e...
Research In Diabetes Technology & Therapeutics Journal Validates Proprietary RF Dielectric Sensor And ML Algorithms For Cla...
Know Labs, Inc. (NYSE:KNW), a leading developer of non-invasive medical diagnostic technology, today announced the publication ...
Benchmark analyst Bruce Jackson reiterates Know Labs (AMEX:KNW) with a Speculative Buy and maintains $1 price target.
Know Labs (AMEX:KNW) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 4...